BIOMAT Database Logo BIOMAT Database Logo

Aminoglycoside and vancomycin pharmacokinetic monitoring in pediatric patients. 1989

A M Bolinger, and M H So, and M E Winter

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008991 Monitoring, Physiologic The continuous measurement of physiological processes, blood pressure, heart rate, renal output, reflexes, respiration, etc., in a patient or experimental animal; includes pharmacologic monitoring, the measurement of administered drugs or their metabolites in the blood, tissues, or urine. Patient Monitoring,Monitoring, Physiological,Physiologic Monitoring,Monitoring, Patient,Physiological Monitoring
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000617 Aminoglycosides Glycosylated compounds in which there is an amino substituent on the glycoside. Some of them are clinically important ANTIBIOTICS. Aminoglycoside
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D014640 Vancomycin Antibacterial obtained from Streptomyces orientalis. It is a glycopeptide related to RISTOCETIN that inhibits bacterial cell wall assembly and is toxic to kidneys and the inner ear. AB-Vancomycin,Diatracin,VANCO-cell,Vanco Azupharma,Vanco-saar,Vancocin,Vancocin HCl,Vancocine,Vancomicina Abbott,Vancomicina Chiesi,Vancomicina Combino Phar,Vancomicina Norman,Vancomycin Hexal,Vancomycin Hydrochloride,Vancomycin Lilly,Vancomycin Phosphate (1:2),Vancomycin Phosphate (1:2), Decahydrate,Vancomycin Sulfate,Vancomycin-ratiopharm,Vancomycine Dakota,Hydrochloride, Vancomycin,Sulfate, Vancomycin

Related Publications

A M Bolinger, and M H So, and M E Winter
Correlation of aminoglycoside and vancomycin pharmacokinetic parameters.
November 1993, The Annals of pharmacotherapy,
A M Bolinger, and M H So, and M E Winter
Optimizing Vancomycin Monitoring in Pediatric Patients.
September 2018, The Pediatric infectious disease journal,
A M Bolinger, and M H So, and M E Winter
Optimizing Vancomycin Monitoring in Pediatric Patients: Erratum.
January 2020, The Pediatric infectious disease journal,
A M Bolinger, and M H So, and M E Winter
Lack of nephrotoxicity in pediatric patients receiving concurrent vancomycin and aminoglycoside therapy.
January 1987, Chemotherapy,
A M Bolinger, and M H So, and M E Winter
An assessment of vancomycin pharmacokinetic variability in pediatric cardiology patients.
April 2003, The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG,
A M Bolinger, and M H So, and M E Winter
Pharmacokinetic analysis of vancomycin in steady state in pediatric cancer patients.
January 1998, Pediatric hematology and oncology,
A M Bolinger, and M H So, and M E Winter
Special considerations for monitoring vancomycin concentrations in pediatric patients.
June 1997, Therapeutic drug monitoring,
A M Bolinger, and M H So, and M E Winter
[Therapeutic monitoring of vancomycin in critical care pediatric patients].
February 2008, Archivos argentinos de pediatria,
A M Bolinger, and M H So, and M E Winter
Vancomycin use and monitoring in pediatric patients in a community hospital.
May 1998, Infection control and hospital epidemiology,
A M Bolinger, and M H So, and M E Winter
Correlation of a Vancomycin Pharmacokinetic Model and Trough Serum Concentrations in Pediatric Patients.
October 2015, The Pediatric infectious disease journal,
Copied contents to your clipboard!